← Toutes les offres
SA

Director - Manufacturing & Technical Operations

Swisslinx AG

Zug, Zg
CDI
Publié le 17 novembre 2026 · Expire le 17 décembre 2026

Description du poste

--- base: meta-keywords: meta-viewport: width=device-width, initial-scale=1.0 title: Director - Manufacturing & Technical Operations (API & DP) ---   Director - Manufacturing & Technical Operations (API & DP) ============================================================= Shape global pharmaceutical manufacturing operations and drive technical excellence from clinical development to commercial readiness. Director - Manufacturing & Technical Operations (API & DP) ============================================================= description: Lead the technical and operational oversight of global Contract Manufacturing Organisations (CMOs) responsible for API and Drug Product manufacturing. Act as the primary technical contact for external manufacturing partners, ensuring manufacturing performance, quality, timelines, and cost efficiency. Drive manufacturing process development, optimisation, scale-up, and continuous improvement across clinical and commercial manufacturing activities. Lead Manufacturing Science & Technology (MS&T) activities, including process characterisation, validation support, troubleshooting, and technical investigations. Manage technology transfers and support the identification and qualification of alternative manufacturing capabilities to strengthen supply security. Develop and coordinate manufacturing strategies, production planning, capacity requirements, and long-term supply readiness. Collaborate closely with Quality, Regulatory Affairs, Clinical Development, and Commercial teams to ensure manufacturing activities meet business and regulatory objectives. Provide strategic technical input into CMO selection, manufacturing network development, operational risk management, and commercial readiness. About the customer: Our client is an international, clinical-stage biopharmaceutical company focused on developing innovative treatments for serious retinal diseases and addressing significant unmet medical needs. With operations spanning North Am